Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
41,037
Value
$2.30M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202641,037$2.30M<0.1%−5,985−12.7%ReducedHolders
Q1 202647,022$2.26M<0.1%−24,903−34.6%ReducedHolders
Q4 202571,925$2.78M<0.1%+18,677+35.1%AddedHolders
Q3 202553,248$1.88M<0.1%−15,921−23.0%ReducedHolders
Q2 202569,169$2.49M<0.1%00.0%UnchangedHolders
Q1 202569,169$2.15M<0.1%+23,021+49.9%AddedHolders
Q4 202446,148$1.18M<0.1%−640−1.4%ReducedHolders
Q3 202446,788$1.32M<0.1%00.0%UnchangedHolders
Q2 202446,788$1.23M<0.1%+1,062+2.3%AddedHolders
Q1 202445,726$1.39M<0.1%00.0%UnchangedHolders
Q4 202345,726$1.28M<0.1%+9,217+25.2%AddedHolders
Q3 202336,509$990.9K<0.1%+18,304+100.5%AddedHolders
Q2 202318,205$559.6K<0.1%+8,982+97.4%AddedHolders
Q1 20239,223$332.3K<0.1%00.0%UnchangedHolders
Q4 20229,223$364.5K<0.1%+2,145+30.3%AddedHolders
Q3 20227,078$285.0K<0.1%+2,447+52.8%AddedHolders
Q2 20224,631$195.0K<0.1%00.0%UnchangedHolders
Q1 20224,631$180.0K<0.1%+1,930+71.5%AddedHolders
Q4 20212,701$107.0K<0.1%−2,380−46.8%ReducedHolders
Q3 20215,081$184.0K<0.1%00.0%UnchangedHolders
Q2 20215,081$209.0K<0.1%+137+2.8%AddedHolders
Q1 20214,944$216.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.